Literature DB >> 22095755

Environmental tobacco smoke and Parkinson's disease.

Susan Searles Nielsen1, Lisa G Gallagher, Jessica I Lundin, W T Longstreth, Terri Smith-Weller, Gary M Franklin, Phillip D Swanson, Harvey Checkoway.   

Abstract

BACKGROUND: Parkinson's disease is inversely associated with cigarette smoking, but its relation with passive smoking or environmental tobacco smoke exposure is rarely examined.
METHODS: Within a case-control study, we assessed the association between Parkinson's disease and living or working with active smokers. Cases were newly diagnosed with idiopathic Parkinson's disease (n = 154) from western Washington State in 2002-2008. Age- and sex-matched controls (n = 173) were neurologically normal and unrelated to cases.
RESULTS: Compared with never active or passive tobacco smokers, we observed reduced Parkinson's disease risks for ever passive only smokers (OR, 0.34; 95% CI, 0.16-0.73), similar to those for ever active smokers (OR, 0.35; 95% CI, 0.17-0.73). Among persons whose only tobacco smoke exposure was passive smoking at home, risk was inversely associated with years exposed.
CONCLUSIONS: These observations parallel those well established for active smoking. However, it remains unresolved whether a true protective effect of tobacco smoke, generally detrimental to health, underlies these associations.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095755      PMCID: PMC3289937          DOI: 10.1002/mds.24012

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

2.  Active and passive smoking and risk of Parkinson's disease.

Authors:  K Tanaka; Yoshihiro Miyake; W Fukushima; S Sasaki; C Kiyohara; Y Tsuboi; T Yamada; T Oeda; T Miki; N Kawamura; N Sakae; H Fukuyama; Y Hirota; M Nagai
Journal:  Acta Neurol Scand       Date:  2010-12       Impact factor: 3.209

3.  Risk and protective factors for Parkinson's disease: a study in Swedish twins.

Authors:  Karin Wirdefeldt; Margaret Gatz; Yudi Pawitan; Nancy L Pedersen
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

4.  Passive smoking and Parkinson disease.

Authors:  George D Mellick; Coral E Gartner; Peter A Silburn; Diana Battistutta
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

5.  A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors.

Authors:  N E Bharucha; L Stokes; B S Schoenberg; C Ward; S Ince; J G Nutt; R Eldridge; D B Calne; N Mantel; R Duvoisin
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

Review 6.  Assessment of exposure to environmental tobacco smoke.

Authors:  M S Jaakkola; J J Jaakkola
Journal:  Eur Respir J       Date:  1997-10       Impact factor: 16.671

7.  Smoking and Parkinson's disease in twins.

Authors:  C M Tanner; S M Goldman; D A Aston; R Ottman; J Ellenberg; R Mayeux; J W Langston
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

8.  Temporal relationship between cigarette smoking and risk of Parkinson disease.

Authors:  E L Thacker; E J O'Reilly; M G Weisskopf; H Chen; M A Schwarzschild; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

9.  Nicotine and cotinine in adults' urine: The German Environmental Survey 1998.

Authors:  Joachim Heinrich; Bernd Hölscher; Margarete Seiwert; Cara L Carty; Günter Merkel; Christine Schulz
Journal:  J Expo Anal Environ Epidemiol       Date:  2005-01

Review 10.  Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?

Authors:  Kay Castagnoli; Thangaraju Murugesan
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more
  22 in total

1.  Parkinson's disease research in a prospective cohort in China.

Authors:  Honglei Chen; Ding Ding; Jian Wang; Qianhua Zhao; Haijiao Meng; Honglan Li; Yu-Tang Gao; Xiao-Ou Shu; Caroline M Tanner; Zhen Hong; Gong Yang
Journal:  Parkinsonism Relat Disord       Date:  2015-08-20       Impact factor: 4.891

Review 2.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

3.  A screening tool to detect clinical manganese neurotoxicity.

Authors:  Brad A Racette; Anat Gross; Susan R Criswell; Harvey Checkoway; Susan Searles Nielsen
Journal:  Neurotoxicology       Date:  2017-03-06       Impact factor: 4.294

4.  Dietary nicotine intake and risk of Parkinson disease: a prospective study.

Authors:  Chaoran Ma; Samantha Molsberry; Yanping Li; Michael Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2020-10-01       Impact factor: 7.045

Review 5.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.

Authors:  Maryka Quik; Danhui Zhang; Matthew McGregor; Tanuja Bordia
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

6.  Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Shu-Ching Hu; Pinky Agarwal; Dora Yearout; Harvey Checkoway
Journal:  J Neural Transm (Vienna)       Date:  2016-06-27       Impact factor: 3.575

7.  LINE-1 DNA methylation, smoking and risk of Parkinson's disease.

Authors:  Susan Searles Nielsen; Harvey Checkoway; Rondi A Butler; Heather H Nelson; Federico M Farin; W T Longstreth; Gary M Franklin; Phillip D Swanson; Karl T Kelsey
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

8.  Nicotine from edible Solanaceae and risk of Parkinson disease.

Authors:  Susan Searles Nielsen; Gary M Franklin; W T Longstreth; Phillip D Swanson; Harvey Checkoway
Journal:  Ann Neurol       Date:  2013-05-09       Impact factor: 10.422

9.  Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study.

Authors:  Maya R Silver; Brad A Racette; Umber Dube; Irene M Faust; Susan Searles Nielsen
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 10.  Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.

Authors:  Xiomara A Perez
Journal:  Neuropsychol Rev       Date:  2015-11-09       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.